UC professor awarded Carnegie fellowship

David Niven to study voting and political polarization

Cincinnati’s NPR station, WVXU, highlighted the University of Cincinnati’s very first Carnegie Award recipient in an interview this week.

Associate professor David Niven, PhD, is a member of the 2025 Andrew Carnegie Fellows Program. He is one of 26 scholars and researchers selected in an application pool of over 300. With a $200,000 grant from the Carnegie Foundation, his research will analyze how American citizens’ experience at the polls impacts their views on voting. 

WVXU’s Becca Costello interviewed Niven about the fellowship and how he plans to tackle the Carnegie Foundation’s focus on researching political polarization. Over the next two years, Niven will use extensive survey work to systematically characterize the voting experience both locally and nationwide. 

"The other half of it is really looking at, how does that voting experience affect our opinions of voting?" Niven told WVXU. "Our thoughts about whether voting is free and fair in this nation or not; our thoughts about what changes should be made to the way we vote."

Read WVXU’s report

Read more about Niven’s research grant.

 

Featured image at top of David Niven. Photo/Andrew Higley/UC Marketing + Brand

Related Stories

2

CCM welcomes new film and media scoring faculty member J.R. Paredes

May 20, 2026

UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.

3

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.